The NHS in the Black Country is now offering the Respiratory Syncytial Virus (RSV) vaccine at selected local pharmacies, making it easier than ever for eligible groups to get protected.

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

It will be available from Autumn for the eligible cohort, including high risk infants and those born too early to be protected by the RSV vaccine offered to pregnant women. Nirsevimab offers over 80% ...

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

The Department of Public Health and Social Services encourages proactive approach to protect oneself and others from health ...

The Department of Public Health and Social Services reminded the community that preventative measures like proper hygiene and ...

New research has suggested that vaccination of pregnant women has been linked to a drop in newborns being admitted to ...

New UK study shows RSV vaccine for pregnant women significantly reduces infant hospital admissions for severe respiratory ...